Chemours Company (NYSE: CC) has a price-to-earnings ratio of 45.68x that is above its average ratio. Additionally, the 36-month beta value for CC is 1.62. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for CC is 148.57M and currently, short sellers hold a 8.94% ratio of that float. The average trading volume of CC on June 03, 2025 was 3.76M shares.
CC) stock’s latest price update
Chemours Company (NYSE: CC) has seen a decline in its stock price by -7.21 in relation to its previous close of 10.13. However, the company has experienced a -8.74% decline in its stock price over the last five trading sessions. newsfilecorp.com reported 2025-06-02 that Toronto, Ontario–(Newsfile Corp. – Le 2 juin/June 2025) – Core Assets Corp. has announced a name change to Core Silver Corp. and a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 12,710,565 common shares.
CC’s Market Performance
Chemours Company (CC) has seen a -8.74% fall in stock performance for the week, with a -22.95% decline in the past month and a -32.18% plunge in the past quarter. The volatility ratio for the week is 4.27%, and the volatility levels for the past 30 days are at 4.31% for CC. The simple moving average for the last 20 days is -14.20% for CC stock, with a simple moving average of -43.82% for the last 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with Mizuho repeating the rating for CC by listing it as a “Outperform.” The predicted price for CC in the upcoming period, according to Mizuho is $19 based on the research report published on March 27, 2025 of the current year 2025.
Truist, on the other hand, stated in their research note that they expect to see CC reach a price target of $27. The rating they have provided for CC stocks is “Buy” according to the report published on January 28th, 2025.
UBS gave a rating of “Buy” to CC, setting the target price at $30 in the report published on July 09th of the previous year.
CC Trading at -19.83% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.57% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from HOSTETTER SHANE, who purchase 4,450 shares at the price of $11.28 back on May 19 ’25. After this action, HOSTETTER SHANE now owns 59,694 shares of Chemours Company, valued at $50,196 using the latest closing price.
Scarborough Alvenia, the SVP Corp Communications & CBO of Chemours Company, sale 7,500 shares at $20.64 during a trade that took place back on Nov 07 ’24, which means that Scarborough Alvenia is holding 16,645 shares at $154,771 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.19 for the gross margin
The net margin for Chemours Company stands at 0.01. The total capital return value is set at 0.07. Equity return is now at value 4.66, with 0.40 for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.1. The debt to equity ratio resting at 7.57. The interest coverage ratio of the stock is 1.56.
Currently, EBITDA for the company is 692.0 million with net debt to EBITDA at 6.12. When we switch over and look at the enterprise to sales, we see a ratio of 0.92. The receivables turnover for the company is 6.76for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.75.
Conclusion
In conclusion, Chemours Company (CC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
